Immune cells recruit T cells into lab-grown Alzheimer’s brain tissue
The immune system is involved in Alzheimer’s disease, but studying how that works in human brain tissue is difficult. Researchers built a three-dimensional brain model in the lab to do exactly that.
A team developed a modular human forebrain organoid, a miniature brain-like structure grown from human stem cells, incorporating both microglia (the brain’s resident immune cells) and CD8 T cells (immune cells that normally fight viruses and cancer). They combined this with Alzheimer’s disease features, including amyloid-beta accumulation. The study was published in eLife.
How microglia attract T cells
The experiments revealed a dual role for microglia. On one hand, they cleared amyloid-beta and supported neuronal maturation. On the other hand, they drove inflammatory activation and recruited CD8 T cells via signalling proteins CCL4 and CCL5. These T cells do not normally appear in the brain in such numbers. Once recruited, they amplified the inflammatory cycle.
The researchers then blocked the signalling pathways CCR5 and CXCR3, through which microglia direct T cells into the brain. Blocking these pathways reduced T cell recruitment and also affected autophagy in microglia. This is an early indication that these signalling routes may represent a potential therapeutic target.
The value of the model
What distinguishes this research is its use of human cell material in a three-dimensional system. Mouse models of Alzheimer’s replicate human pathology only partially. A human stem cell organoid gives researchers greater control over which cell types are present and how they interact.
The model is a research tool, not a treatment. But it gives scientists a way to study neuroimmune interactions in Alzheimer’s disease in a system closer to human biology, potentially narrowing the path toward new therapies.
Search terms for further research: brain organoid Alzheimer neuroimmmunology, microglia T cell recruitment CCL4, amyloid-beta immune response brain